Bhat Laxminarayan

Insider Reports History

Reporting-owner location: Cupertino, CA
Latest reporting-owner signature: /s/ Narayan Prabhu, Attorney-in-Fact
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Bhat Laxminarayan

Form 4 holding President and CEO, Director

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Security class: Stock Option (right to buy)
Shares / value: 109,150
Estimated value
Report date: 18 Mar 2026
Price
Ownership: Direct
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount

Form 4 holding President and CEO, Director

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Security class: Stock Option (right to buy)
Shares / value: 40,925
Estimated value
Report date: 18 Mar 2026
Price
Ownership: By Spouse
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount

Insider Reports Filed by Bhat Laxminarayan

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 18 Mar 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 20 Mar 2026, 17:00
Role: President and CEO, Director
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 13 Feb 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 18 Feb 2025, 16:30
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 15 Sep 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 17 Sep 2024, 17:01
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Report period: 25 Apr 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 27 Apr 2023, 16:31
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .